5 senior medical science liaison jobs found

Our team of expert medical affairs physicians and scientists at Regeneron bridge the gap between our innovative medicines and the scientific and healthcare community. As the Director Medical Affairs Hematology, you will represent Regeneron in Medical Affairs and Clinical Development providing scientific and medical leadership for our Hematology assets. In this strategic role, you will work within a multifunctional, matrix organization, aligning with Global and US teams to ensure that medical and clinical activities in Germany are in sync with global strategies and goals. You will collaborate with internal colleagues across Medical Affairs, Clinical Sciences, Operations, and Regulatory, and provide guidance to Commercial teams. As the key medical resource for Hematology in Germany, you will be instrumental in enhancing Regeneron's presence in the field, reporting to the Senior Medical Director DACH, and leading a dedicated medical team. A typical day might include: Acting as...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible. Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us . Position Summary: BMS...

IQVIA is seeking a high-performing Business Development and Account Management individual to join our MedTech team in the role of Senior Global Account Director, MedTech. This is a pivotal role at an exciting time, as we continue to expand and evolve the MedTech business through deep industry expertise and a commitment to truly understanding our clients. As a Senior Global Account Director, you will spearhead strategic client engagements, lead new and thought-provoking discussions to challenge status quo, and provide innovative solutions that address our clients’ key business challenges in the MedTech industry . Success in this role requires a strong appreciation of the IQVIA offerings, with the ability to leverage an internal network to orchestrate integrated, end-to-end solutions. You will play a critical role in developing large, complex, and long-term engagements that strengthen client relationships and amplify the value we bring to our clients. The IQVIA...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...